Skip to main content
    M

    Merit Medical Systems Inc (MMSI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $86.35
    -0.28 (-0.32%)

    Market Cap: $5.19B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Merit Medical Systems Inc (MMSI) Earnings: Report Dates and Results

    Updated Oct 29, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Merit Medical Systems (MMSI) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, Merit Medical Systems reported EPS of $1.01, above the $0.93 estimate. It beat the EPS estimate in each of the last 28 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +24.61%
    Streak
    28 Q

    Upcoming Estimates

    Reports Feb 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.13
    Range$1.07 - $1.19
    14 analysts
    Revenue Consensus
    $430.84M
    Range$412.76M - $446.15M
    14 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.02
    Range$0.99 - $1.05
    9 analysts
    EPS Revisions
    3
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.01+1.1%
    60d ago$1.02+0.9%
    30d ago$1.02+0.9%
    7d ago$1.02+0.9%
    Current$1.02
    Revenue Consensus
    $408.89M
    Range$402.87M - $414.10M
    8 analysts

    Next Report

    MMSI has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 8.7% above the $1.04 reported for the quarter ended Dec 31, 2025.

    MMSI Earnings Call

    The latest MMSI earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, MMSI beat 38 and missed 2. Revenue for the quarter ended Sep 30, 2026 was $416.24M, up 8.4% from $384.16M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.01$0.93N/A+8.60%Beat+9.8%116 up, 1 downOct 29, 2026$416.24M
    Jun 30, 2026$1.09$0.85N/A+28.24%Beat+7.9%90 up, 1 downJul 30, 2026$418.84M
    Mar 31, 2026$0.94$0.83$0.81 - $0.85+13.25%Beat+9.3%100 up, 8 downApr 30, 2026$381.88M
    Dec 31, 2025$1.04$0.95$0.93 - $0.98+9.50%Beat+11.8%101 up, 0 downFeb 24, 2026$393.94M
    Sep 30, 2025$0.92$0.83$0.80 - $0.86+10.84%Beat+7.0%108 up, 1 downOct 30, 2025$384.16M
    Jun 30, 2025$1.01$0.85$0.83 - $0.88+18.82%Beat+9.8%101 up, 0 downJul 30, 2025$382.46M
    Mar 31, 2025$0.86$0.75$0.74 - $0.76+14.67%Beat+11.7%100 up, 6 downApr 24, 2025$355.35M
    Dec 31, 2024$0.93$0.83$0.81 - $0.85+12.05%Beat+14.8%93 up, 0 downFeb 25, 2025$355.16M
    Sep 30, 2024$0.86$0.80$0.79 - $0.81+7.50%Beat+14.7%100 up, 0 downOct 30, 2024$339.85M
    Jun 30, 2024$0.92$0.87$0.84 - $0.89+5.75%Beat+13.6%100 up, 0 downAug 1, 2024$338.00M
    Mar 31, 2024$0.77$0.72$0.71 - $0.72+6.94%Beat+20.3%90 up, 0 downApr 30, 2024$323.51M
    Dec 31, 2023$0.81$0.77$0.75 - $0.79+5.19%Beat+2.5%80 up, 0 downFeb 28, 2024$324.51M
    Sep 30, 2023$0.75$0.65$0.64 - $0.66+15.38%Beat+17.2%70 up, 0 downOct 26, 2023$315.23M
    Jun 30, 2023$0.81$0.76$0.74 - $0.78+6.58%Beat+11.0%70 up, 0 downJul 25, 2023$320.06M
    Mar 31, 2023$0.64$0.55$0.53 - $0.56+16.36%Beat+20.8%70 up, 0 downApr 26, 2023$297.56M
    Dec 31, 2022$0.79$0.67$0.65 - $0.69+17.91%Beat+11.3%70 up, 0 downFeb 22, 2023$293.42M
    Sep 30, 2022$0.64$0.53$0.51 - $0.55+20.75%Beat+23.1%70 up, 0 downOct 26, 2022$287.18M
    Jun 30, 2022$0.73$0.58$0.55 - $0.60+25.86%Beat+17.7%70 up, 0 downJul 27, 2022$294.98M
    Mar 31, 2022$0.53$0.47$0.45 - $0.48+12.77%Beat+1.9%70 up, 0 downApr 27, 2022$275.42M
    Dec 31, 2021$0.71$0.52$0.49 - $0.54+36.54%Beat+31.5%70 up, 0 downFeb 24, 2022$278.49M
    Sep 30, 2021$0.52$0.44$0.39 - $0.49+18.18%Beat+23.8%8N/AOct 28, 2021$267.02M
    Jun 30, 2021$0.62$0.45$0.42 - $0.46+37.78%Beat+100.0%8N/AJul 29, 2021$280.32M
    Mar 31, 2021$0.52$0.36$0.33 - $0.41+44.44%Beat+36.8%8N/AApr 29, 2021$248.91M
    Dec 31, 2020$0.54$0.43$0.38 - $0.46+25.58%Beat+35.0%8N/AFeb 24, 2021$258.00M
    Sep 30, 2020$0.42$0.20$0.13 - $0.24+110.00%Beat+50.0%8N/AOct 28, 2020$243.97M
    Jun 30, 2020$0.31$0.07-$0.09 - $0.17+342.86%Beat-26.2%8N/AJul 29, 2020$218.37M
    Mar 31, 2020$0.38$0.26$0.20 - $0.35+46.15%Beat+2.7%8N/AApr 23, 2020$243.53M
    Dec 31, 2019$0.40$0.34$0.33 - $0.37+17.65%Beat-16.7%8N/AFeb 24, 2020$257.92M
    Sep 30, 2019$0.28$0.45$0.43 - $0.47-37.78%Miss-40.4%8N/AOct 30, 2019$243.05M
    Jun 30, 2019$0.42$0.50$0.47 - $0.51-16.00%Miss-2.3%6N/AJul 25, 2019$255.53M
    Mar 31, 2019$0.37$0.36$0.35 - $0.37+2.78%Beat+19.4%8N/AApr 23, 2019$238.35M
    Dec 31, 2018$0.48$0.45$0.42 - $0.48+6.67%Beat+45.5%8N/AFeb 26, 2019$233.25M
    Sep 30, 2018$0.47$0.42$0.41 - $0.43+11.90%Beat+46.9%8N/AOct 25, 2018$221.66M
    Jun 30, 2018$0.43$0.40$0.37 - $0.42+7.50%Beat+19.4%8N/AJul 23, 2018$224.81M
    Mar 31, 2018$0.31$0.29$0.23 - $0.33+6.90%Beat+10.7%8N/AApr 25, 2018$203.03M
    Dec 31, 2017$0.33$0.32$0.30 - $0.33+3.13%Beat+6.5%7N/AFeb 28, 2018$190.90M
    Sep 30, 2017$0.32$0.30$0.28 - $0.31+6.67%Beat+23.1%8N/AOct 25, 2017$179.34M
    Jun 30, 2017$0.36$0.29$0.28 - $0.31+24.14%Beat+38.5%8N/AJul 26, 2017$186.55M
    Mar 31, 2017$0.28$0.23N/A+21.74%Beat+47.4%N/AN/AApr 27, 2017$171.07M
    Dec 31, 2016$0.31$0.28N/A+10.71%Beat+29.2%N/AN/AFeb 21, 2017$157.72M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $3.83, up 10.1% from the year before. It was $1.02 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$3.83+10.1%
    Dec 31, 2024$3.48+15.6%
    Dec 31, 2023$3.01+11.9%
    Dec 31, 2022$2.69+13.5%
    Dec 31, 2021$2.37+43.6%
    Dec 31, 2020$1.65+12.2%
    Dec 31, 2019$1.47-13.0%
    Dec 31, 2018$1.69+31.0%
    Dec 31, 2017$1.29+26.5%
    Dec 31, 2016$1.02N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,000 words across 15 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,00315
    2026Q2Jun 30, 20267,86114
    2026Q1Mar 31, 20266,94913
    2025Q4Dec 31, 20258,26611
    2025Q3Sep 30, 202510,04412
    2025Q2Jun 30, 20258,75413
    2025Q1Mar 31, 20259,31714
    2024Q4Dec 31, 20246,73713

    2026Q3 Earnings Call

    Opening remarks

    Martha Aronson President and Chief Executive Officer Thank you, operator, and welcome, everyone. I am joined on the call today by Raul Parra, our Chief Financial Officer and Treasurer; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary. Brian, would you please take us through the safe harbor statements?

    Brian Lloyd Chief Legal Officer and Corporate Secretary Thank you, Martha. This presentation contains forward-looking statements that receive safe harbor protection under federal securities laws. Our actual results may differ materially from the expectations and projections expressed or implied by our forward-looking statements. Please refer to the sections entitled "Cautionary Statement" regarding forward-looking statements in today's press release and presentation for important information regarding such statements. In addition, any forward-looking statements represent our views only as of today, October 29, 2026, and should not be relied upon as representing our views as of any other date. We specifically disclaim any obligation to update such statements, except as required by applicable law. This presentation also contains certain non-GAAP financial measures. A reconciliation of non-GAAP financial measures to the most directly comparable U.S. GAAP measures is included in today's press release and presentation furnished to the SEC under Form 8-K. Please refer to the sections of our press release and presentation entitled "Non-GAAP Financial Measures" for important information regarding non-GAAP financial measures discussed on this call. Both today's press release and our presentation are available on the Investors page of our website. I will now turn the call back to Martha.

    Martha Aronson President and Chief Executive Officer Thank you, Brian. Let me start with a brief agenda of what we will cover during our prepared remarks. I will begin with a brief summary of the third quarter financial results; then I will provide several operational updates and progress areas in Q3; Raul will then provide a more in-depth review of the quarterly financial results, as well as our financial guidance for 2026, which we updated in today's press release; then we will open the call for your questions. Beginning with a review of our third quarter results. For avoidance of doubt, all growth figures are on a constant currency basis, unless otherwise noted. We reported total revenue of $416 million, up 8% year-over-year on both a GAAP and constant currency basis. Our total revenue results exceeded the high end of the expectations that we outlined on our Q2 earnings call. Third quarter total constant currency growth was driven by 9% organic growth, which also exceeded the high end of our expectations, and follows the 9% organic growth we delivered in Q2. By way of reminder, our organic growth excludes the contributions from acquisitions in the current year period and revenue from divested products in the prior year period. We saw strong growth trends in the U.S.

    Frequently Asked Questions About MMSI

    When is Merit Medical Systems's next earnings date?

    Merit Medical Systems's next earnings report is expected for Feb 22, 2027.

    Did MMSI beat earnings estimates last quarter?

    Yes. Merit Medical Systems reported EPS of $1.01 for the quarter ended Sep 30, 2026, above the $0.93 estimate, a 8.60% surprise.

    What EPS do analysts expect from MMSI next quarter?

    The consensus EPS estimate for Merit Medical Systems for the quarter ending Dec 31, 2026 is $1.13 from 14 analysts, with estimates from $1.07 to $1.19.

    How often does MMSI beat earnings estimates?

    Merit Medical Systems beat the EPS estimate in each of the last 28 quarters, with an average surprise of +33.43%.